These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19896447)

  • 61. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
    Martina BE; Koraka P; van den Doel P; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2008 Jan; 26(2):153-7. PubMed ID: 18069096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
    Alonso-Padilla J; de Oya NJ; Blázquez AB; Escribano-Romero E; Escribano JM; Saiz JC
    Vaccine; 2011 Feb; 29(9):1830-5. PubMed ID: 21211580
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
    Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The E glycoprotein plays an essential role in the high pathogenicity of European-Mediterranean IS98 strain of West Nile virus.
    Alsaleh K; Khou C; Frenkiel MP; Lecollinet S; Vàzquez A; de Arellano ER; Després P; Pardigon N
    Virology; 2016 May; 492():53-65. PubMed ID: 26896935
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1.
    Sun EC; Zhao J; Liu NH; Yang T; Ma JN; Geng HW; Wang LF; Qin YL; Bu ZG; Yang YH; Lunt RA; Wang LF; Wu DL
    J Gen Virol; 2012 Jan; 93(Pt 1):50-60. PubMed ID: 21940411
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.
    Dunn MD; Rossi SL; Carter DM; Vogt MR; Mehlhop E; Diamond MS; Ross TM
    Virol J; 2010 May; 7():95. PubMed ID: 20462412
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.
    Chang GJ; Davis BS; Stringfield C; Lutz C
    Vaccine; 2007 Mar; 25(12):2325-30. PubMed ID: 17224209
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model.
    Szentpáli-Gavallér K; Lim SM; Dencső L; Bányai K; Koraka P; Osterhaus AD; Martina BE; Bakonyi T; Bálint Á
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26907325
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.
    Brandler S; Marianneau P; Loth P; Lacôte S; Combredet C; Frenkiel MP; Desprès P; Contamin H; Tangy F
    J Infect Dis; 2012 Jul; 206(2):212-9. PubMed ID: 22551814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.
    Lieberman MM; Clements DE; Ogata S; Wang G; Corpuz G; Wong T; Martyak T; Gilson L; Coller BA; Leung J; Watts DM; Tesh RB; Siirin M; Travassos da Rosa A; Humphreys T; Weeks-Levy C
    Vaccine; 2007 Jan; 25(3):414-23. PubMed ID: 16996661
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
    Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry.
    Wang J; Yang J; Ge J; Hua R; Liu R; Li X; Wang X; Shao Y; Sun E; Wu D; Qin C; Wen Z; Bu Z
    Virol J; 2016 Jun; 13():109. PubMed ID: 27342050
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1.
    Yeh JY; Chung KM; Song J
    Vector Borne Zoonotic Dis; 2012 May; 12(5):380-7. PubMed ID: 22217168
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.
    Seregin A; Nistler R; Borisevich V; Yamshchikov G; Chaporgina E; Kwok CW; Yamshchikov V
    Virology; 2006 Dec 5-20; 356(1-2):115-25. PubMed ID: 16935318
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
    Verstrepen BE; Oostermeijer H; Fagrouch Z; van Heteren M; Niphuis H; Haaksma T; Kondova I; Bogers WM; de Filette M; Sanders N; Stertman L; Magnusson S; Lőrincz O; Lisziewicz J; Barzon L; Palù G; Diamond MS; Chabierski S; Ulbert S; Verschoor EJ
    PLoS One; 2014; 9(11):e112568. PubMed ID: 25392925
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.
    Iyer AV; Pahar B; Boudreaux MJ; Wakamatsu N; Roy AF; Chouljenko VN; Baghian A; Apetrei C; Marx PA; Kousoulas KG
    Vaccine; 2009 Feb; 27(6):893-903. PubMed ID: 19070640
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.